AdvertisementAdvertise with NZME.
Latest from Best of Business Analysis
<i>Yoke Har Lee:</i> Firm plays NZ drawcard to win drug trials
High standards and lower costs have helped to gain contracts from international pharmaceutical firms.
<i>Liam Dann</i>: It's about ordinary investors
The Hanover investors who grudgingly voted for the Allied Farmers deal probably haven't had time to digest the contents of the capital markets report.
<i>Fran O'Sullivan</i>: A new year, and a new game
John Key is promising senior business leaders that 2010 will be a 'game-changer'.
<i>Anthony Doesburg:</i> Google makes messaging even more instant
If you're not a fan of instant messaging (IM), you're going to hate a new PC-based communication tool under development by Google.
<i>Jane Diplock:</i> Much to consider for Hanover investors
In a rare move, Securities Commission chairwoman Jane Diplock gives her views on the decision facing Hanover Finance debenture holders.